RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Englewood, CO · +26 more sites